Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: a preview of ASCO; Roche CEO on new opportunities; Sanofi sees success in MS; Phase II lupus win for AbbVie; and a Chinese product case study in psoriasis.
Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 2 June 2023, including: a preview of ASCO; Roche Holding AG pharma CEO on new opportunities; Sanofi sees success in MS; Phase II lupus win for AbbVie Inc.; and a Chinese product case study in psoriasis.
This and all our other podcasts are available on the Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
(Also see "ASCO Preview: Five Top Late-Breakers To Watch For" - Scrip, 26 May, 2023.)
(Also see "Roche Pharma CEO Graham On Growth Prospects, Policy Pressures, Alzheimer’s And More" - Scrip, 25 May, 2023.)
(Also see "Sanofi Moves Up In MS With Frexalimab Success" - Scrip, 31 May, 2023.)
(Also see "AbbVie's Rinvoq Succeeds Against The Odds In Phase II Lupus Trial" - Scrip, 31 May, 2023.)
(Also see "Falling At The Start Line: Chinese Firms Face Multiple Commercial Challenges Beyond Price, Coverage" - Scrip, 30 May, 2023.)